Innovation Adoption: ‘Medtech’s Ongoing Challenge Of The Day’

UK Health Care System Faces Tough Short- And Medium-Term Conditions

UK ministers are increasingly focusing on the need to improve uptake of new technologies in the National Health Service. Ambitious programs have been launched but implementing them effectively for lasting change in a delivery system under acute stress is a challenge of a different order.

Two doctors looking at screens of information to represent the concept of remote medicine.
• Source: Shutterstock

Much talk in UK health care innovation circles in the fall of 2023 has surrounded IDAP, the new Innovative Devices Access Pathway focusing on unmet needs. Health authorities see the pathway as a vehicle for speeding promising pre-regulatory medtech and healthtech solutions into clinical use in the National Health Service.

IDAP has learnt from its precursor sister program in pharma, ILAP, but the principles are the same. IDAP has been...

More from Global Vision

More from In Vivo

Can Italy Shake Off Its Reputation And Become A Premier Hub For Biotech?

 
• By 

Leading industry experts have spoken to In Vivo about how investment, a change in mindset and a fresh approach to policy may allow Italy to kick-start its biotech ecosystem.

Rising Leaders 2025: Abbas Kazimi’s Vision For Nimbus Therapeutics

 
• By 

Rising Leader Abbas Kazimi's leadership at Nimbus Therapeutics combines immigrant resilience, patient-first partnerships, contrarian strategic bets and a deeply personal mission driving breakthrough drug discovery innovation.

Trojan Bio Eyes Perfect Rainbow Shot With Immune System Cancer Innovations

 
• By 

Trojan Bio’s proprietary platform, based on engineered antibodies that activate the immune system to fight cancer in the same way as common viral infections, won Biomed Israel's 2025 biopharma start-up award. CEO and cofounder Anat Burkovitz said the technology is attracting investors' attention.